Copyright Reports & Markets. All rights reserved.

Global Pulmonary Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Pulmonary Drugs Market Overview

      • 1.1 Product Overview and Scope of Pulmonary Drugs
      • 1.2 Pulmonary Drugs Segment by Type
        • 1.2.1 Global Pulmonary Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Inhaled Corticosteroids
        • 1.2.3 Long Acting Beta-2 Agonists
        • 1.2.4 Antihistamines
        • 1.2.5 Vasodilators
        • 1.2.6 Others
      • 1.3 Pulmonary Drugs Segment by Application
        • 1.3.1 Pulmonary Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Asthma & COPD
        • 1.3.3 Allergic Rhinitis
        • 1.3.4 Pulmonary Arterial Hypertension
        • 1.3.5 Cystic Fibrosis
        • 1.3.6 Others
      • 1.4 Global Pulmonary Drugs Market by Region
        • 1.4.1 Global Pulmonary Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Pulmonary Drugs Market Size
        • 1.5.1 Global Pulmonary Drugs Revenue (2014-2025)
        • 1.5.2 Global Pulmonary Drugs Production (2014-2025)

      2 Global Pulmonary Drugs Market Competition by Manufacturers

      • 2.1 Global Pulmonary Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Pulmonary Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Pulmonary Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Pulmonary Drugs Production Sites, Area Served, Product Types
      • 2.5 Pulmonary Drugs Market Competitive Situation and Trends
        • 2.5.1 Pulmonary Drugs Market Concentration Rate
        • 2.5.2 Pulmonary Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Pulmonary Drugs Production Market Share by Regions

      • 3.1 Global Pulmonary Drugs Production Market Share by Regions
      • 3.2 Global Pulmonary Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Pulmonary Drugs Production
        • 3.4.1 North America Pulmonary Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Pulmonary Drugs Production
        • 3.5.1 Europe Pulmonary Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Pulmonary Drugs Production (2014-2019)
        • 3.6.1 China Pulmonary Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Pulmonary Drugs Production (2014-2019)
        • 3.7.1 Japan Pulmonary Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Pulmonary Drugs Consumption by Regions

      • 4.1 Global Pulmonary Drugs Consumption by Regions
      • 4.2 North America Pulmonary Drugs Consumption (2014-2019)
      • 4.3 Europe Pulmonary Drugs Consumption (2014-2019)
      • 4.4 China Pulmonary Drugs Consumption (2014-2019)
      • 4.5 Japan Pulmonary Drugs Consumption (2014-2019)

      5 Global Pulmonary Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Pulmonary Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Pulmonary Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Pulmonary Drugs Price by Type (2014-2019)
      • 5.4 Global Pulmonary Drugs Production Growth by Type (2014-2019)

      6 Global Pulmonary Drugs Market Analysis by Applications

      • 6.1 Global Pulmonary Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Pulmonary Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Pulmonary Drugs Business

      • 7.1 Sanofi SA
        • 7.1.1 Sanofi SA Pulmonary Drugs Production Sites and Area Served
        • 7.1.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.1.3 Sanofi SA Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Meda Pharmaceuticals
        • 7.2.1 Meda Pharmaceuticals Pulmonary Drugs Production Sites and Area Served
        • 7.2.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.2.3 Meda Pharmaceuticals Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Circassia Pharmaceuticals Plc.
        • 7.3.1 Circassia Pharmaceuticals Plc. Pulmonary Drugs Production Sites and Area Served
        • 7.3.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.3.3 Circassia Pharmaceuticals Plc. Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 AstraZeneca Plc.
        • 7.4.1 AstraZeneca Plc. Pulmonary Drugs Production Sites and Area Served
        • 7.4.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.4.3 AstraZeneca Plc. Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 GlaxoSmithKline Plc.
        • 7.5.1 GlaxoSmithKline Plc. Pulmonary Drugs Production Sites and Area Served
        • 7.5.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.5.3 GlaxoSmithKline Plc. Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Mallinckrodt Pharmaceuticals Plc.
        • 7.6.1 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Production Sites and Area Served
        • 7.6.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.6.3 Mallinckrodt Pharmaceuticals Plc. Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Cheisi Farmaceutici S.p.A
        • 7.7.1 Cheisi Farmaceutici S.p.A Pulmonary Drugs Production Sites and Area Served
        • 7.7.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.7.3 Cheisi Farmaceutici S.p.A Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Zambon Company S.p.A
        • 7.8.1 Zambon Company S.p.A Pulmonary Drugs Production Sites and Area Served
        • 7.8.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.8.3 Zambon Company S.p.A Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Alaxia SAS
        • 7.9.1 Alaxia SAS Pulmonary Drugs Production Sites and Area Served
        • 7.9.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.9.3 Alaxia SAS Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Merck Sharp & Dohme Limited
        • 7.10.1 Merck Sharp & Dohme Limited Pulmonary Drugs Production Sites and Area Served
        • 7.10.2 Pulmonary Drugs Product Introduction, Application and Specification
        • 7.10.3 Merck Sharp & Dohme Limited Pulmonary Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Pulmonary Drugs Manufacturing Cost Analysis

      • 8.1 Pulmonary Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Pulmonary Drugs
      • 8.4 Pulmonary Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Pulmonary Drugs Distributors List
      • 9.3 Pulmonary Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Pulmonary Drugs Market Forecast

      • 11.1 Global Pulmonary Drugs Production, Revenue Forecast
        • 11.1.1 Global Pulmonary Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Pulmonary Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Pulmonary Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Pulmonary Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Pulmonary Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Pulmonary Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Pulmonary Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Pulmonary Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Pulmonary Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Pulmonary Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Pulmonary Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Pulmonary Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Pulmonary Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Pulmonary Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Pulmonary Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The pulmonary drugs are used for treating the conditions affecting lungs. The pulmonary drugs are used from treating minor illnesses such as the common cold to cure long-term disorders such asthma. These agents are available in different forms such as oral tablets, oral liquids, and injections or inhalations. Inhalations deliver the medicine directly to the lungs, which can act directly on the lung tissues, minimizing systemic side effects.
        The major factors driving growth of the pulmonary drugs market include increasing incidence of chronic respiratory diseases, tobacco smoking, and government and non-government initiatives.

        The global Pulmonary Drugs market is valued at 30400 million US$ in 2018 is expected to reach 56600 million US$ by the end of 2025, growing at a CAGR of 8.1% during 2019-2025.
        This report focuses on Pulmonary Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Pulmonary Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Sanofi SA
        Meda Pharmaceuticals
        Circassia Pharmaceuticals Plc.
        AstraZeneca Plc.
        GlaxoSmithKline Plc.
        Mallinckrodt Pharmaceuticals Plc.
        Cheisi Farmaceutici S.p.A
        Zambon Company S.p.A
        Alaxia SAS
        Merck Sharp & Dohme Limited

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Inhaled Corticosteroids
        Long Acting Beta-2 Agonists
        Antihistamines
        Vasodilators
        Others

        Segment by Application
        Asthma & COPD
        Allergic Rhinitis
        Pulmonary Arterial Hypertension
        Cystic Fibrosis
        Others

        Buy now